CXCR4 Modified Anti-BCMA CAR T Cells for Multiple Myeloma
NCT04727008
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
BIOLOGICAL:
CXCR4 modified anti-BCMA CAR T cells
Sponsor
Sichuan University